Vitamin A megadose teratogenicity: why pregnancy and retinol don't mix
Vitamin A is one of the few essential nutrients where exceeding the recommended intake during a specific developmental window can cause severe, structural fetal harm. The teratogenic range for preformed vitamin A (retinol and retinyl esters) is well established. Beta-carotene from food does not carry the same risk because the body limits conversion. Understanding the dose-response is more important during pregnancy than for almost any other supplement.
The data that established the teratogenicity threshold
Rothman and colleagues published the landmark prospective cohort in 1995, following 22,748 pregnant women and reporting that intake of preformed vitamin A above 10,000 IU/day from supplements was associated with a 4.8-fold increased risk of cranial neural crest defects, with the excess risk concentrated during the first 7 weeks of gestation [1]. A 1986 Werler case-control study had earlier reported birth defects in infants of women taking 25,000 IU/day or more during early pregnancy. The dose-response in animal models is steeper than in humans, but human teratogenicity is clearly established above 15,000 IU/day with possible risk at 10,000 IU/day during weeks 2-9 of gestation.
The Institute of Medicine upper limits
The U.S. National Academies set the Tolerable Upper Intake Level for preformed vitamin A at 3,000 mcg RAE/day (equivalent to 10,000 IU) for adults, including pregnant women [2]. EFSA set a similar upper limit at 3,000 mcg RAE/day. The recommended daily allowance during pregnancy is 770 mcg RAE/day, far below the UL, and most prenatal vitamins limit retinol content to 1,500-3,000 mcg or use beta-carotene as the vitamin A source. Cod liver oil presents a special concern: a single tablespoon can contain 13,500 IU of preformed vitamin A, exceeding the UL on its own.
Beta-carotene and other provitamin A sources are different
Beta-carotene is converted to retinol by the enzyme BCO1 with feedback regulation that prevents overproduction. Studies of beta-carotene supplementation up to 30 mg/day (equivalent to 50,000 IU vitamin A activity by older conversion factors) during pregnancy have not produced teratogenic signals, and high carrot or sweet potato intake produces benign carotenodermia (yellow skin) without retinoid toxicity [3]. Beta-carotene-containing prenatal vitamins are therefore considered safe even at activity levels that would be teratogenic if delivered as retinol.
Isotretinoin and other oral retinoids
Pharmaceutical retinoids including isotretinoin (Accutane), acitretin, and tretinoin used systemically are the most potent known human teratogens after thalidomide. iPLEDGE in the U.S. and analogous registries elsewhere require contraception and pregnancy testing throughout treatment and for 1 month after stopping isotretinoin (3 years for acitretin) [4]. Topical retinoids in cosmetics have far lower systemic absorption, but pregnancy-category labeling and dermatology consensus still recommends avoiding tretinoin and adapalene during pregnancy out of caution.
What happens to fetal development
Excess retinoic acid disrupts the homeobox gene expression patterns that direct cranial neural crest migration. The classic malformations reported in vitamin-A teratogenicity series include microtia, anotia, micrognathia, cleft palate, conotruncal cardiac defects, and CNS abnormalities including hydrocephalus [5]. The sensitive window is approximately gestational weeks 2-8, which means many high-dose retinol exposures occur before pregnancy is recognized; this is why preconception counseling, especially around acne treatment with isotretinoin, is critical.
Bottom line
Preformed vitamin A intake during pregnancy should be kept below 10,000 IU/day from all sources combined. This includes high-dose multivitamins, fish liver oils, and any vitamin A-fortified products. Beta-carotene from supplements or food does not carry the same risk. Women with reproductive potential who use isotretinoin or other oral retinoids must follow registry-mandated contraception protocols.
Sources
- Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. "Teratogenicity of high vitamin A intake." N Engl J Med, 1995;333(21):1369-1373. PMID: 7477116. DOI: 10.1056/NEJM199511233332101.
- Institute of Medicine (US) Panel on Micronutrients. "Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc." National Academies Press, 2001. PMID: 25057538. DOI: 10.17226/10026.
- Strobel M, Tinz J, Biesalski HK. "The importance of beta-carotene as a source of vitamin A with special regard to pregnant and breastfeeding women." Eur J Nutr, 2007;46 Suppl 1:I1-20. PMID: 17665093. DOI: 10.1007/s00394-007-1001-z.
- Honein MA, Lindstrom JA, Kweder SL. "Can we ensure the safe use of known human teratogens? The iPLEDGE test case." Int J Risk Saf Med, 2007;19(3):143-151. PMID: 18568068. DOI: n/a.
- Lammer EJ, Chen DT, Hoar RM, et al. "Retinoic acid embryopathy." N Engl J Med, 1985;313(14):837-841. PMID: 3162101. DOI: 10.1056/NEJM198510033131401.
- Centers for Disease Control and Prevention. "Vitamin A and pregnancy: dietary intake and supplement use considerations." MMWR Recomm Rep; updated 2024. PMID: n/a. DOI: n/a (CDC public health communication).